Tbahriti H F, Messaoudi A, Kaddous A, Bouchenak M, Mekki K
Laboratoire de nutrition clinique et métabolique, faculté des sciences de la nature et de la vie, université d'Oran, Oran 31100, Algérie.
Service de biochimie, établissement hospitalier universitaire (EHU) d'Oran, Oran 31037, Algérie.
Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):135-9. doi: 10.1016/j.ancard.2014.04.016. Epub 2014 May 2.
To evaluate pro-inflammatory cytokines, homocysteinemia and markers of oxidative status in the course of chronic renal failure.
One hundred and two patients (male/female: 38/64; age: 45±07 years) with chronic renal failure were divided into 4 groups according to the National Kidney Foundation classification. They included 28 primary stage renal failure patients, 28 moderate stage renal failure, 28 severe stage renal failure and 18 end stage renal failure. The inflammatory status was evaluated by the determination of pro-inflammatory cytokines (tumor necrosis factor-α, interleukin-1β, interleukin-6) and total homocysteine. Pro-oxidant status was assessed by assaying thiobarbituric acid reactive substances, hydroperoxides, and protein carbonyls. Antioxidant defence was performed by analysis of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase.
Inflammatory markers were elevated in the end stage renal failure group compared to the other groups (P<0.001). Indeed, an increase in thiobarbituric acid reactive substances, hydroperoxides and protein carbonyls was noted in the end stage renal failure group in comparison with the other groups (P<0.001), while the levels of antioxidants enzymes activity were decreased in the study population (P<0.001).
Impaired renal function is closely associated with the elevation of inflammatory markers leading to both increased markers of oxidative stress and decreased antioxidant defense.
评估慢性肾衰竭过程中促炎细胞因子、高同型半胱氨酸血症及氧化状态标志物。
102例慢性肾衰竭患者(男/女:38/64;年龄:45±7岁)根据美国国家肾脏基金会分类法分为4组。包括28例初期肾衰竭患者、28例中度肾衰竭患者、28例重度肾衰竭患者及18例终末期肾衰竭患者。通过测定促炎细胞因子(肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6)及总同型半胱氨酸评估炎症状态。通过检测硫代巴比妥酸反应性物质、氢过氧化物及蛋白质羰基评估促氧化状态。通过分析超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶、谷胱甘肽还原酶进行抗氧化防御评估。
与其他组相比,终末期肾衰竭组炎症标志物升高(P<0.001)。事实上,与其他组相比,终末期肾衰竭组硫代巴比妥酸反应性物质、氢过氧化物及蛋白质羰基增加(P<0.001),而研究人群中抗氧化酶活性水平降低(P<0.001)。
肾功能受损与炎症标志物升高密切相关,导致氧化应激标志物增加及抗氧化防御降低。